Ambicare CE marks skin cancer photodynamic therapy
This article was originally published in Clinica
Executive Summary
Ambicare has CE marked its lead product, Ambulight PDT, a photodynamic therapy, for sale in Europe to treat non-melanoma skin cancer. The firm claims it is the world’s first light-emitting sticking plaster for the treatment of skin cancer.